Evidence map›Paper›PMID 32613050›Full record

ArticleArthroplasty today2020

Hospital and Surgeon Medicare Reimbursement Trends for Total Joint Arthroplasty.

Cesar D Lopez, Venkat Boddapati, Alexander L Neuwirth, Roshan P Shah, H John Cooper, Jeffrey A Geller

Abstract read
In one paragraph

Article in Arthroplasty today, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Gender-Based Differences in Arthroplasty Utilization Across Two Tertiary Academic Centers.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Early Readmission and Revision After Total Joint Arthroplasty: An Analysis of Cause and Cost.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cesar D LopezDepartment of Orthopedic Surgery, Columbia University Irving Medical Center, New York, NY, USA.
Venkat BoddapatiDepartment of Orthopedic Surgery, Columbia University Irving Medical Center, New York, NY, USA.
Alexander L NeuwirthDepartment of Orthopedic Surgery, Columbia University Irving Medical Center, New York, NY, USA.
Roshan P ShahDepartment of Orthopedic Surgery, Columbia University Irving Medical Center, New York, NY, USA.
H John CooperDepartment of Orthopedic Surgery, Columbia University Irving Medical Center, New York, NY, USA.
Jeffrey A GellerDepartment of Orthopedic Surgery, Columbia University Irving Medical Center, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOver 1 million total joint arthroplasties (TJAs) are performed every year in the United States, creating Medicare cost concerns for policy makers. The purpose of this study is to evaluate recent trends in Medicare utilization and reimbursements to hospitals/surgeons for TJAs between 2012 and 2017.

methodsWe tracked annual Medicare claims and payments to TJA surgeons using publicly available Medicare databases and aggregated data at the county level. Descriptive statistics and multivariate regression models were used to evaluate trends in procedure volume, utilization (per 10,000 Medicare beneficiaries), and reimbursement rates and to examine associations between county-specific variables and TJA utilization and reimbursements.

resultsBetween 2012 and 2017, there was an 18.9% increase in annual primary TJA volume (357,500 cases in 2012 to 425,028 cases in 2017) and a 2.0% increase in annual primary TJA per capita utilization (73.4 cases per 10,000 Medicare beneficiaries in 2012 to 74.8 in 2017). The Midwest and the South had higher utilization rates compared with the Northeast and West (

conclusionsDespite increasing TJA volume and utilization, surgeon reimbursements have continued to decline, whereas hospital payments and hospital charges have increased significantly more than surgeon charges. Cost containment efforts will need to address other expenditures such as hospital costs and implant costs to better align financial risks and incentives for TJA surgeons.

Indexed as

Health-care costsMedicareReimbursementsTotal joint arthroplastyUtilization

Identifiers

PMID32613050
PMCPMC7320234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.